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ABSTRACT		St	John's	wort	(also	known	as	hypericum,	millepertuis)	is	Hypericum	perforatum	L.,	Hypericaceae,	an	her-baceous	perennial	plant	native	to	Europe	and	Asia,	and	which	has	been	introduced	into	the	United	States	where	it	has	naturalized.	The	chemical	composition	of	St.	John's	wort	has	been	well-studied.	Documented	pharmacological	activities,	including	antidepressant,	antiviral,	and	antibacterial	effects,	provide	supporting	evidence	for	several	of	the	traditional	uses	stated	for	St	John's	wort.	Many	pharmacological	activities	appear	to	be	attributable	to	hypericin	and	to	the	flavanoid	constituents;	hypericin	is	also	reported	to	be	responsible	for	the	photosensitive	reactions	that	have	been	documented	for	St.	John's	wort.	This	systematic	review	over-views	the	literature	on	the	use	of	St.	John’s	Wort	for	chemistry,	pharmacology	and	clinical	properties.		 	
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INTRODUCTION	
Hypericum	 perforatum	L.	 (St.	 John’s	wort)	 is	 a	 five-petalled,	yellow-flowered	perennial	weed	common	to	the	western	United	States,	Europe,	and	Asia.	[1]There	are	 several	 explanations	 as	 to	 the	 origins	 of	 the	names	hypericum	and	St	John's	wort.	Commonly,	the	name	hypericum	 is	believed	 to	be	derived	 from	the	Greek	wordshyper	(over)	and	eikon	(image),	and	the	name	St	 John's	wort	may	have	arisen	as	 the	 ¯owers	bloom	 around	 St	 John's	 Day	 (June	 24).	 Hypericum	
perforatum	 is	 native	 to	parts	 of	Europe	and	Asia	 [2]	but	has	spread	worldwide	as	a	cosmopolitan	invasive	
weed	 [3,	 4],	 including	 to	 temperate	 regions	 of	 India,	China,	Canada,	Africa,	and	the	United	States	[5].			Hypericum	 perforatum	 is	 a	 five-petal	 perennial	flowering	plant	notable	for	its	ability	to	treat	mild	to	moderate	 depression.[6,7]	 Historically,	 hypericum	was	 used	 in	 patients	with	 feelings	 of	 isolation	who	lacked	community	and	felt	separated	from	the	rest	of	the	world.	It	has	been	described	as	a	“wound	healer”	for	nervous	individuals[8,9].	The	flowers	measures	up	to	 2.5	 cm	 across,	 has	 five	 petals,	 and	 are	 colored	bright	yellow	with	conspicuous	black	dots	[10,	11].	The	flowers	appear	in	broad	cymes	at	the	ends	of	the	up-per	branches,	between	late	spring	and	early	to	mid-summer.	The	sepals	are	pointed,	with	black	glandular	dots.	 There	 are	many	 stamens,	which	 are	 united	 at	the	base	into	three	bundles.	The	pollen	grains	are	el-lipsoidal.	 Studies	 have	 supported	 the	 efficacy	 of	 St	John's	wort	as	a	treatment	for	depression	in	humans	
[12].	It	has	superior	efficacy	to	placebo	in	treating	de-pression;	 is	 as	 effective	 as	 standard	 antidepressant	pharmaceuticals	 for	 treating	 depression;	 and	 has	fewer	adverse	effects	than	other	antidepressants.	St.	John's	wort	(Hypericum	perforatum)	has	antioxidant,	anti-inflammatory,	anticancer,	and	antimicrobial	ac-tivities[13].	
Monograph	Common	name:	St	John’s	wort	Other	 names:	 Hypericum,	 amber,	 goat	 weed,	 john-wort,	 Klamath	 weed,	 tipton	 weed,	 hardhay,	prikbladet	perikon,	hartheu,	herb	de	millepertuis,	hy-perici	 herba,	 iperico,	 johanniskraut,	 sonnenwend-kraut[14].		
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Figure	1:	Hypericum	perforatum	Family:	Clusiaceae	Parts	used:	above	ground	parts	
Active	Constituents	St.	 John’s	wort	 has	 a	 complex	 and	diverse	 chemical	makeup.	 Constituents	 include	 volatile	 oils	 (0.05	 to	0.3%,	 including	 α-pinene,	 and	 cineole),	 anthraqui-nones,	carotenoids,	cumarine,	flavonoids	(0.5-	1.0%,	including	 hyperoside,	 quercetin,	 and	 rutin),	 naph-thodianthrones	 (0.1-0.3%	of	which	80-90%	are	hy-pericin	 and	 pseudohypericin),	 carbolic	 acids,	phloroglucins	(up	to	3%	hyperforin),	xanthones,	and	proanthocyanidins.[15]	 The	 naphthodianthrones	 hy-pericin	 and	 pseudohypericin	 previously	 received	most	of	the	attention	in	pharmacological	studies.	This	is	based	on	their	contributions	to	the	antiviral	prop-erties	 of	 the	 plant	 as	well	 as	 speculation	 (based	 on	early	 in	vitro	data)	 that	 they	may	also	contribute	 to	the	plant’s	 antidepressant	 actions.[16]	This	may	par-tially	 explain	 why	 many	 extracts	 continue	 to	 be	standardized	to	contain	measured	amounts	of	hyper-icin.	 Recent	 research,	 however,	 indicates	 that	 other	constituents	 such	 as	 hyperforin,	 [17,18]	 and	 possibly	flavonoid	compounds,	may	also	contribute	to	the	an-tidepressant	actions	of	the	plant.	
Historical	use	St	John’s	wort	has	a	long	history	of	usage,	being	used	in	antiquity	 for	 the	 treatment	of	burns,	 snake	bites,	fever	 and	 wounds.	 During	 the	 medieval	 period,	 St.	John’s	wort	was	ascribed	almost	magical	powers	of	protection	against	evil	spirits	because	of	its	associa-tion	with	St.John	the	Baptist.	The	yellow	petals	when	bruised	 show	 a	 reddish	 mark	 that	 symbolized	 the	bloodshed	by	the	saint.	Hung	in	the	house	or	rubbed	over	the	lintels,	the	herb	would	prevent	witches	and	death	from	entering	during	the	year.	Wort	is	from	the	old	English	wyrt,	meaning	a	plant	or	herb,	especially	one	used	in	medicine.	Paracelsus,	the	swiss	physician,	chemist	and	natural	philosopher	who	lived	in	the	16th	century,	wrote	of	the	superior	healing	powers	of	St.	Johns	 Wort	 as	 menopausal	 neurosis,	 other	 indica-tions	 listed	are	 excitability,	 neuralgia,	 fibrosis’s	 and	sciatica.[14]	
Mechanism	of	action	A	number	of	proposed	mechanisms	exist	for	St.	John’s	wort’s	antidepressant	effect,	involving	several	neuro-transmitters	 and	 hormones.	 Initially,	 inhibition	 of	monoamine	 oxidase	 (MAO)	 was	 believed	 to	 be	 the	
primary	mode	of	action,[19]	and	was	thought	to	be	due	primarily	to	hypericin.[20]		Hypericin	and	hypericin-like	constituents	may	possi-bly	act	on	acetyl	cholinesterase	by	reducing	the	deg-radation	 rate	 of	 acetylcholine.[21]Sedative	 actions	come	 from	 the	 hypericins,	 bioflavones,	 and	 hyper-phoria.	Other	reports	demonstrate	a	serotonergic	ac-tivity	[22]	that	causes	hypericum	to	act	like	a	weak	ser-otonin	reuptake	inhibitor	(SSRI),	but	with	fewer	side	effects	than	its	pharmaceutical	counterpart.[23]		Hypericum	 may	 encourage	 production	 of	 thyroid-stimulating	hormone,	though	a	clear	link	has	not	been	established.[24]	Hyperforin	has	also	been	shown	 to	have	antimicro-bial	 activity	 against	 gram-positive	 bacteria	 and	 nu-merous	viruses.	This	property	is	 likely	attributed	to	the	essential	oils,	phloroglucinol,	and	flavonoid	con-stituents,	and	may	involve	a	photo	activation	process	that	 disrupts	 certain	 components	 of	 the	 organism’s	cell	membrane.[25,26]	The	antitumor	properties	of	St.	John’s	 wort	 are	 attributed	 to	 hypericin,	 which	 is	 a	powerful	 photo	 sensitizer.	Once	 taken	up	by	 tumor	cells,	hypericin	reacts	in	the	presence	of	oxygen	and	activates	multiple	apoptosis	pathways	that	results	in	malignant	cell	death.[27,28]	
Chemistry	The	major	 active	 constituents	 are	 considered	 to	 be	hyperforin	 (a	 prenylated	 phloroglucinol;	 Figure	 1)	and	hypericin	 (a	 naphthodianthrone;	 Figure	2),	 alt-hough	other	biologically	active	constituents,	 eg	 ¯fla-vonoids,	 tannins,	 are	 also	 present.[29]	 The	 constitu-ents	 of	 St	 John's	 wort	 (Hypericum	 perforatum	 L.),	compiled	 from	 several	 sources	 (Bisset	 1994)	 Bom-bardelli	&	Morazzoni	1995;[30-31]	
	
Figure	2:	Chemical	structure	of	hyperforin	
	
Figure	3:	Chemical	structure	of	hypericin	
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Pharmacology	Several	pharmacological	activities,	 including	antide-pressant,	 antiviral,	 and	 antibacterial	 effects,	 have	been	 documented	 for	 extracts	 of	 St	 John's	 wort	and}or	its	constituents	[37]	
Anticancer	effect	Hyperforin	has	also	been	investigated	in	animals	and	
in	vitro	studies	for	its	antitumor	effects.	Schrempf	et	al	 found	hyperforin	 dose	dependently	 inhibited	 the	growth	in	vitro	of	rat	and	human	mammary	cancer,	as	well	 as	 squamous	 cell	 carcinoma,	 malignant	 mela-noma,	 and	 lymphoma	better	 than	or	 equal	 to	 other	cytostatic	 drugs	 tested,	 including	 camptothecin,	paclitaxel,	and	vincristine.	The	data	revealed	hyper-forin	appears	to	induce	tumor	cell	apoptosis	via	acti-vation	of	mitochondria,	release	of	cytochrome	c,	and	caspase	activation,	which	all	in	turn	trigger	cell	death	pathways.	 Further	 research	 in	 this	 area	 is	 indi-cated.[39]	The	role	of	Hypericum	perforatum	and	neem	oil	in	the	treatment	of	acute	skin	toxicity	for	patients	undergo-ing	 radiotherapy	 or	 chemo-radiotherapy	 for	 head	and	neck	cancer	was	evaluated.	This	oil	proved	to	be	a	safe	and	active	option	in	the	management	of	acute	skin	toxicity	in	head	and	neck	cancer	patients	submit-ted	to	RT	or	chemo	radiotherapy.	A	prophylactic	ef-fect	in	the	prevention	of	moist	desquamation	may	be	hypothesized	for	hypericum	and	neem	oil	and	need	to	be	tested	within	a	prospective	controlled	study	[40].	The	Hypericum	constituent,	hypericin,	is	a	powerful	photosensitizing	agent	and	 its	use	 in	photodynamic	
therapy	for	cancer	patients	has	gained	the	attention	of	researchers	for	over	a	dozen	years.	Numerous	 in	vitro	studies	 [41-44]	have	 investi-gated	its	effect	on	various	cell	lines.	These	studies	all	demonstrate	 hypericin’s	 cytotoxic	 effect	 on	 tumor	cells	after	photosensitization.	
Antidepressant	activity	The	precise	mechanism	of	action	for	the	antidepres-sant	effect	of	St	John's	wort	is	unclear.	Initially,	atten-tion	was	focused	on	hypericin	as	the	constituent	of	St	John's	wort	believed	to	be	responsible	for	the	herb's	antidepressant	 effects.	 However,	 experimental	 has	now	emerged	to	indicate	that	hyperforin	is	one	of	the	major	constituents	required	for	antidepressant	activ-ity.[45	-46]	
Wound	healing	St.	 John’s	wort	has	 long	been	used	successfully	as	a	remedy	for	wound	healing,	and	research	in	humans	supports	 its	effectiveness	 in	 this	arena.	 	All	patients	were	treated	twice	daily	for	16	days	and	Sur-face	Perimeter	Area	(SPA)	of	the	surgical	wound	was	measured	 before	 and	 after	 treatment.	 Patients	treated	 with	 the	 Hypericum/Calendula	 mixture	 ex-hibited	 a	 significant	 decrease	 (approximately	 38%)	in	 the	 SPA	 of	 the	 surgical	 wound	 compared	 to	 pa-tients	in	the	placebo	group	(approximately	16%).[50]	
Hypericum	in	Pregnancy	Despite	 considerable	 scientific	 investigation,	 rela-tively	little	information	has	been	garnered	regarding	
Table	1:	Phytoconstiuents	of	Hypericum	perforatum		
S.No Constituents  
1 Flavanoids 
Flavonols (e.g. kaempferol, quercetin), ¯avones (e.g. 
luteolin) and glycosides (e.g. hyperoside, isoquercitrin, 
quercitrin, rutin), bi¯avonoids including biapigenin (a 
¯avone) and amento¯avone (a biapigenin derivative)[32] 
2 Tannins Proanthocyanidins (condensed type) have been reported [31] 
3 Anthraquinone derivatives (naphthodianthrones) 
Hypericin, pseudohypericin, and isohypericin; protohypericin, and pro-
topseudohypericin (biosynthetic precursors of hypericin and pseudohy-
pericin, respectively) 
Cyclopseudohypericin, Hypericin  pseudohypericin [33]. 
4 Prenylated phloroglu-cinols Hyperforin  adhyperforin 
[34] 
5 Other phenols Caffeic, chlorogenic, p-coumaric, ferulic, p-hydroxybenzoic and vanillic acids. 
6 Volatile oils (0.05±0.9%) 
methyl-2- octane (saturated hydrocarbon); others include nnonane and 
traces of methyl-2-decane and n-undecane 
(saturated hydrocarbons; Brondz et al 1983), a- and bpinene, a- terpin-
eol, geraniol, and traces of myrcene and 
limonene (monoterpenes), caryophyllene and humulene 
(sesquiterpenes) [35] 
7 Other constituents 
Acids (isovalerianic, nicotinic, myristic, palmitic, stearic), 
carotenoids, choline, nicotinamide, pectin, b-sitosterol, 
straight chain saturated hydrocarbons (C16, C30) 
and alcohols (C24, C26, C28) [36] 
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the	 use	 of	 hypericum	 for	 depression	 during	 preg-nancy.	A	few	animal	studies	have	investigated	its	ef-fect	on	pregnancy	and	progeny.	A	study	in	rats	using	doses	 up	 to	 25	 times	 the	 equivalent	 recommended	human	 dose	 throughout	 gestation	 was	 unable	 to	show	any	neurobehavioral	or	developmental	effects	on	 the	 offspring.	Maternal	weight	 gain	 or	 length	 of	gestation,	 likewise,	was	not	 affected	 [51].	 	Other	mu-rine	studies	showed	no	significant	 impact	on	cogni-tion	or	behavioral	tasks.	In	1998,	 there	were	 reports	on	2	women	who	 took	hypericum	 in	 their	 pregnancies	 to	 avoid	 the	 use	 of	conventional	 synthetic	 medications.	 Both	 cases	seemed	to	reveal	no	concerns.	One	of	these	cases	was	of	a	38-year-old	woman	who	started	hypericum	at	24	weeks	gestation.	The	pregnancy	was	unremarkable,	with	the	exception	of	late	onset	of	thrombocytopenia,	which	the	author	did	not	attribute	to	hypericum.	The	offspring	 was	 born	 healthy,	 had	 a	 normal	 birth	weight,	normal	APGAR	scores,	and	physical	examina-tion	 and	 laboratory	 results	were	normal.	 Infant	be-havioral	assessment	at	4	and	23	days	was	normal.	[52]	
Antiviral	activity	Hypericin	 has	 also	 been	 reported	 to	 inactivate	mu-rine	cytomegalovirus	(MCMV)	and	Sindbis	virus	 [47].	The	antiviral	activity	of	hypericin	appears	to	involve	a	photo	activation	process		Flavonoid-	 and	 catechin-containing	 fractions	 of	 St	John's	wort	have	exhibited	activity	against	influenza	virus	[48].		Hypericin	and	pseudo	hypericin	have	been	reported	 to	 inhibit	 several	 encapsulated	 viruses	 in-vitro,	 including	herpes	simplex	virus	 types	1	and	2.	
[49]	Hypericin	 is	 a	 well	 known	 photosenvsitizing	 agent	used	in	the	photodynamic	therapy	of	cancer	and	viral	infections.	 The	 photodynamic	 therapy	 involves	 the	combination	 of	 photosensitizing	 agent	 and	 visible	light	at	the	absorption	wavelength	of	the	compound.	Lavie	et	al	demonstrated	 [53]	 the	 inhibitory	effect	of	hypericin	and	pseudohypericin	against	vesicular	sto-matitis,	influenza	virus	and	herpes	simplex	virus	type	II	ans	I.	Both	hypericin	and	pseudohypericin	prevents	the	viral	fusion	by	the	generation	of	singlet	oxygen	up	on	illumination	[54].	
Antimicrobial	activity	Hyperforin	 is	reported	to	have	antibacterial	activity	against	Staphylococcus	aureus	[55].	Antibacterial	activ-ity	of	hyperforin	against	multidrug-resistant	S.	aureus	and	Gram-positive	 bacteria,	 including	Streptococcus	
pyogenes	and	Corynebacterium	diphtheriae,	has	been	reported	 [56].	However,	 it	has	been	emphasised	 that	the	 antibacterial	 effects	 of	 hyperforin	 are	 only	 ob-served	at	high	concentrations	[57-58]	
Hypericum	Interactions		Although	now	not	considered	a	concern	regarding	in-teraction	with	monoamine	oxidase	(MAO)–inhibiting	
drugs	 or	 tyramine	 containing	 foods,	 hypericum	has	been	shown	to	have	the	ability	to	either	enhance	or	reduce	 the	 circulating	 levels	 of	 certain	 drugs.	 [59-61]	Hypericum	is	known	to	induce	enzymes	of	the	cyto-chrome	P450	system	(3A4	and	1A2)	as	well	as	P-gly-coprotein	from	the	intestinal	wall.	Hypericum	inter-acts	with	and	lowers	the	effectiveness	of	oral	contra-ceptives.	 If	 a	 patient	 is	 taking	 specific	 or	 multiple	medications,	hypericum	should	be	used	with	caution	or	 avoided	 altogether,	 and	 other	 options	 should	 be	considered.			
Medications	Known	to	Interact	with	Hypericum	Alprazolam,	 Amitriptyline,	 Cyclosporine,	 Digoxin,	Indinavir,	 Irinotecan,	 Methadone,	 Nevirapine,	 Oral	contraceptives,	Phenprocoumon,	Simvastatin,	Tacro-limus,	 Theophylline,	 Topo	 II-poisoning	 chemother-apy	regimens,	Verapamil,	Warfarin.	
CONCLUSION	The	review	describes	chemical	profile,	pharmacology	with	special	reference	to	hypericin.	The	vast	body	of	research,	as	well	as	historical	use,	suggests	 that	hy-pericum	 is	 a	 useful	 as	 part	 of	 a	 broader	 treatment	plan	 for	adults	with	minor	 to	moderate	depression.	Emergent	 studies	 suggest	 that	 hypericum	 may	 be	helpful	and	does	not	cause	any	birth	defects,	may	be	useful	 in	adolescents	with	depression,	and	has	a	 fa-vorable	 side	 effect	 profile.	 However,	 hypericum	 is	known	to	have	 interactions	and	modulate	the	phar-macokinetics	of	many	medications.	As	a	result,	 cau-tion	is	recommended	with	patients	on	medication(s).		Concerns	have	been	raised	over	interactions	between	St	John's	wort	and	certain	prescribed	medicines	(in-cluding	warfarin,	cyclosporine,	theophylline,	digoxin,	HIV	 protease	 inhibitors,	 anticonvulsants,	 selective	serotonin	 reuptake	 inhibitors,	 triptans,	 oral	 contra-ceptives);	advice	 is	 that	patients	 taking	 these	medi-cines	should	stop	taking	St	John's	wort,	generally	af-ter	seeking	professional	 advice	 as	 dose	 adjustment	 of	 conven-tional	treatment	may	be	necessary.	Some	studies	in	basic	research	however	do	report	on	anti-inflammatory	and	analgesic	effects	of	H.	perfora-tum.	We	therefore	encourage	further	studies	with	ho-meopathic	Hypericum	in	both	basic	research	and	ran-domized	controlled	clinical	trials	in	dental	practice	
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